Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Overview of autism genetics
- Illustrations of the heterogeneity of autism
- Rare vs. common variants (1)
- Rare vs. common variants (2)
- Common variant common disease
- Genome wide association
- Rare variation
- Rare variants and gene discovery
- The logic behind the outlier strategy
- Specific genes from outlier findings
- The synapse
- CNVs
- CNVs and autism
- Findings in AUT challenge Mendelian expectations
- Rare vs. common variants (3)
- Addressing association
- Clinical genetics evaluation
- Genetic testing
- Summary
- Acknowledgements
Topics Covered
- Overview of autism genetics
- Rare vs. common variants
- Whole genome association
- Rare variants and gene discovery
- Copy number variation (CNVs)
- CNVs and autism
- Association
- Clinical genetics evaluation
- Genetic testing
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
State, M. (2010, February 23). Genetics of autism spectrum disorders [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/DTUA3973.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Matthew State has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Neuroscience
Transcript
Please wait while the transcript is being prepared...
0:00
Hi. I'm Matt State and I'd
like to talk to you today
about the genetics of
autism spectrum disorders.
I am the Donald J. Cohen,
Associate professor of Child
Psychiatry and Genetics.
I co-direct the program on
neurogenetics and serve
as Deputy Chairman
for Research within the
Department of Psychiatry
at the Yale School of Medicine.
0:20
Let me start by reviewing
for you the topics I'd
like to cover today.
First, I'm going to address
the challenges that
have faced researchers
attempting to identify
specific genes contributing
to idiopathic autism.
That is autism.
That is not a consequence
of a rare genetic syndrome.
I'm going to move from
there to describe
some basic issues
in human genetics,
and I'm going
particularly to focus on
the difference between
genetic variation
that's rare in the
population versus
genetic variation that's
common in the population.
That will then serve
as a prelude for
a review of recent
findings in the field.
I'm going to
particularly highlight
the last 3-4 years of
research as this has
been a particularly
productive time for
gene discovery in autism and
autism spectrum disorders.
I'm going to conclude
then with a discussion
of how these recent
findings are beginning
to inform the clinical
evaluation of children
presenting with autism
spectrum disorders.
1:16
Let me begin by describing
for you some of the evidence
suggesting that genes are
important to look at in autism,
that they're playing
a significant role in
the etiology and pathogenesis
of autism spectrum disorders.
A strong piece of evidence
that this is the case
comes from comparing the rate at
which monozygotic twins
share a diagnosis of autism or
autism spectrum disorder
versus the rate at
which dizygotic twins
share such a diagnosis.
The key difference
between these types of
twin pairs is the amount
of DNA that they share.
Monozygotic twins share all
of their DNA exactly alike.
and dizygotic twins share
only as much genetic material
as any sibling pair.
The observation that
monozygotic twins
are much more likely to
share a diagnosis of
autism or autism
spectrum disorders than
dizygotic twins
suggests that genes are
carrying the lion's
share of risk for ASD.
In fact, this calculation
suggests that autism is the most
genetic or most heritable
of all neuropsychiatric
syndromes.
In addition to the twin data,
we see many families
clinically in
which there's familial
aggregation of autism.
There are many multiplex or
multiple affected families,
but what's also clear
is that few families
present to clinic in
which there's an obvious,
simple or Mendelian pattern of
transmission from
generation to generation.
In fact, this observation,
along with now several
decades of efforts to
identify genes
contributing to autism,
have led to a widespread
consensus that writ large as
a general proposition
autism is not
the consequence of a mutation
in just a single gene.
In fact, what's thought
is that autism is
a highly genetically
heterogeneous disorder,
and we can think about
heterogeneity in a variety
of different ways.
One way that
geneticists think about
heterogeneity is something
called locus heterogeneity.
What this would mean is that
multiple different
genes around the genome
might all either
contribute to or lead
to a similar or
overlapping phenotype.
This is somewhat different than
a second related notion
called allelic heterogeneity,
in which even if there's
a single gene that is
contributing some risk to autism,
there may be many ways in
which that gene might vary in
terms of its sequence or
its structure that may
contribute to autism.
It is the general conclusion
of the field that
autism is characterized
both by a high degree of
locus heterogeneity and
allelic heterogeneity.
While there is this
type of agreement,
there is not agreement on
precisely how many
genes are contributing,
both in the sense
of an individual,
how many different genetic
kits, if you will,
might be necessary
in order to lead
someone to have a clinical
presentation of autism.
Also, then how many genes
or how many different spots
around the genome
might be contributing
in the population in general.